Protagonist Therapeutics, Inc. (PTGX)

NASDAQ: PTGX · Real-Time Price · USD

55.33

-1.11 (-1.97%)

At close: Jul 18, 2025, 4:00 PM

53.00

-2.33 (-4.21%)

After-hours: Jul 18, 2025, 7:26 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Peptide Therapeutics	434.43M	Log In	Log In	Log In	Log In	Upgrade
Peptide Therapeutics Growth	624.05%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	434.43M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	624.05%	Log In	Log In	Log In	Log In	Upgrade